APA
Montalescot G., Zeymer U., Silvain J., Boulanger B., Cohen M., Goldstein P., Ecollan P., Combes X., Huber K., Pollack C., Bénezet J., Stibbe O., Filippi E., Teiger E., Cayla G., Elhadad S., Adnet F., Chouihed T., Gallula S., Greffet A., Aout M., Collet J. & Vicaut E. (20110913). Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. : Lancet (London, England).
Chicago
Montalescot Gilles, Zeymer Uwe, Silvain Johanne, Boulanger Bertrand, Cohen Marc, Goldstein Patrick, Ecollan Patrick, Combes Xavier, Huber Kurt, Pollack Charles, Bénezet Jean-François, Stibbe Olivier, Filippi Emmanuelle, Teiger Emmanuel, Cayla Guillaume, Elhadad Simon, Adnet Frédéric, Chouihed Tahar, Gallula Sébastien, Greffet Agnès, Aout Mounir, Collet Jean-Philippe and Vicaut Eric. 20110913. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. : Lancet (London, England).
Harvard
Montalescot G., Zeymer U., Silvain J., Boulanger B., Cohen M., Goldstein P., Ecollan P., Combes X., Huber K., Pollack C., Bénezet J., Stibbe O., Filippi E., Teiger E., Cayla G., Elhadad S., Adnet F., Chouihed T., Gallula S., Greffet A., Aout M., Collet J. and Vicaut E. (20110913). Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. : Lancet (London, England).
MLA
Montalescot Gilles, Zeymer Uwe, Silvain Johanne, Boulanger Bertrand, Cohen Marc, Goldstein Patrick, Ecollan Patrick, Combes Xavier, Huber Kurt, Pollack Charles, Bénezet Jean-François, Stibbe Olivier, Filippi Emmanuelle, Teiger Emmanuel, Cayla Guillaume, Elhadad Simon, Adnet Frédéric, Chouihed Tahar, Gallula Sébastien, Greffet Agnès, Aout Mounir, Collet Jean-Philippe and Vicaut Eric. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. : Lancet (London, England). 20110913.